Daclizumab: outcome of phase III trials and mechanism of action. Double Therapy and the Triple Therapy Study Groups.

  • F Vincenti
  • Björn Nashan
  • S Light

Bibliographical data

Original languageGerman
Article number5
ISSN0041-1345
Publication statusPublished - 1998
pubmed 9723424